MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1310.50%
Quick Ratio
1302.72%
Cash Ratio
1217.39%
Debt to Asset Ratio
22.53%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Accounts receivable, net
    • Property and equipment, net
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Notes payable, net
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
598,641
666,699
737,060
344,772
Accounts receivable, net
30,261
24,347
30,650
30,768
Inventory
3,826
3,737
3,564
3,488
Prepaid expenses and other current assets
11,699
11,212
10,855
7,952
Total current assets
644,427
705,995
782,129
386,980
Property and equipment, net
19,456
18,425
19,676
16,954
Restricted cash
1,614
1,614
1,614
1,614
Operating lease assets
5,820
6,495
4,638
5,334
Total assets
671,317
732,529
808,057
410,882
Accounts payable
6,996
8,026
4,154
6,260
Accrued expenses and other current liabilities
39,056
36,487
43,835
40,272
Operating lease liabilities
3,122
3,170
2,817
2,762
Total current liabilities
49,174
47,683
50,806
49,294
Operating lease liabilities, net of current portion
3,466
4,230
2,815
3,629
Derivative liability
10,910
12,071
13,903
14,962
Deferred revenue
14,000
14,000
14,000
14,000
Notes payable, net
72,795
72,062
71,336
70,617
Other non-current liabilities
931
909
887
151
Total liabilities
151,276
150,955
153,747
152,653
Common stock, 0.0001 par value 400,000,000 and 400,000,000 shares authorized and 219,589,303 and 215,927,600 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
22
22
22
18
Additional paid-in capital
1,844,417
1,827,187
1,811,311
1,350,580
Accumulated deficit
-1,324,398
-1,245,635
-1,157,023
-1,092,369
Total stockholders' equity
520,041
581,574
654,310
258,229
Total liabilities and stockholders' equity
671,317
732,529
808,057
410,882
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$598,641K (53.05%↑ Y/Y)Accounts receivable, net$30,261K (-0.50%↓ Y/Y)Prepaid expenses andother current assets$11,699K (33.09%↑ Y/Y)Inventory$3,826K (25.90%↑ Y/Y)Total current assets$644,427K (48.70%↑ Y/Y)Property and equipment,net$19,456K (85.99%↑ Y/Y)Operating lease assets$5,820K (-1.07%↓ Y/Y)Restricted cash$1,614K (0.00%↑ Y/Y)Total assets$671,317K (48.74%↑ Y/Y)Total liabilities andstockholders' equity$671,317K (48.74%↑ Y/Y)Total stockholders'equity$520,041K (69.99%↑ Y/Y)Total liabilities$151,276K (4.03%↑ Y/Y)Accumulated deficit-$1,324,398K (-29.47%↓ Y/Y)Additional paid-in capital$1,844,417K (38.80%↑ Y/Y)Notes payable, net$72,795K (4.13%↑ Y/Y)Total currentliabilities$49,174K (14.54%↑ Y/Y)Deferred revenue$14,000K (0.00%↑ Y/Y)Derivative liability$10,910K (-22.20%↓ Y/Y)Operating leaseliabilities, net of current...$3,466K (-21.37%↓ Y/Y)Other non-currentliabilities$931K (529.05%↑ Y/Y)Common stock, 0.0001par value...$22K (29.41%↑ Y/Y)Accrued expenses andother current...$39,056K (13.48%↑ Y/Y)Accounts payable$6,996K (18.80%↑ Y/Y)Operating leaseliabilities$3,122K (18.93%↑ Y/Y)

OCULAR THERAPEUTIX, INC (OCUL)

OCULAR THERAPEUTIX, INC (OCUL)